ArticleCancer cell2020

Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation.

Zeda Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.